Remove Adverse Reactions Remove Labelling Remove Presentation
article thumbnail

Over-the-Counter Choices Pharmacist Role and Resources

FADIC

OTC drugs come in various forms, including tablets, capsules, creams, and liquids, and are generally labeled with clear instructions on proper usage and dosage. The FDA’s website provides a wealth of information on OTC drugs, including product labels, warnings, and recalls.

article thumbnail

Pharmacovigilance deep dive: risk minimisation measures

European Pharmaceutical Review

This can be achieved by reducing the burden of adverse reactions or by optimising benefits through patient selection (eg, contraindications, recommendations of use, warnings, concomitant medicine[s], or certain test parameters) and treatment management (eg, specific dosing regimen, relevant testing, patient follow-up).

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

OPDP Says TV Ad is Out of Bounds with Fourth Untitled Letter of 2024

FDA Law Blog: Biosimilars

The approved labeling for UBRELVY includes a warning and precaution regarding hypersensitivity reactions, with the most common adverse reactions being nausea and somnolence. on March 10, 2020. New sponsors take note – when acquiring a new drug from another company, GET THE REGULATORY CORRESPONDENCE.

article thumbnail

How advanced technology can streamline the COVID-19 vaccine rollout

pharmaphorum

Adverse reactions to the vaccine. After collecting the information, they print a plastic barcode label that can send the recipient’s vaccination records to the cloud with a simple scan. In a rollout of this magnitude, point of care facilities need to collect comprehensive vaccination data on: Individual patient records.

Vaccines 119
article thumbnail

FDA Accepts Pfizer’s sNDA for BRAFTOVI + MEKTOVI

LifeProNow

These sNDAs are supported by results from the PHAROS trial ( NCT03915951 ), an open-label, multicenter, non-randomized, Phase 2 study (n=98) to determine the safety, tolerability, and efficacy of BRAFTOVI given in combination with MEKTOVI in patients with BRAF V600E-mutant metastatic NSCLC. of patients.

article thumbnail

Nextstellis®: A new drug update 

Birth Control Pharmacist

Adverse Reactions. The most common adverse reactions (>2%) were bleeding irregularities, dysmenorrhea, headaches, mood disturbance, increase weight, acne, decrease libido and breast symptoms. Breakthrough bleeding was present in 33.8% Managing Adverse Effects of Hormonal Contraceptives.”

article thumbnail

BMS Submits Application for Abecma® for Relapsed or Refractory Multiple Myeloma

LifeProNow

Identify CRS based on clinical presentation. We hope to be able to offer the option of CAR T cell therapy to patients with relapsed or refractory multiple myeloma in Japan in their earlier treatment stages at the same time as the U.S. and Europe.” Evaluate for and treat other causes of fever, hypoxia, and hypotension.